-
Rite Aid Q2 beats Street; cuts outlook on lower reimbursements, generics
Camp Hill, Pa. -- Rite Aid Corp. on Thursday reported better-than-expected profit and sales for the second quarter. But the chain cut its full-year profit outlook, citing lower reimbursement rates and anticipated lower profitability from new generics and generic drugs that recently lost exclusivity.
Rite Aid’s second-quarter profit surged to $129.2 million, up from $32.8 million in the year-earlier period,